Nicolas M Geis - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Cancers|August 27, 2021

PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future PerspectivesMohamed El Fakiri, Nicolas M Geis, Nawal Ayada, et al.

Theranostics|January 9, 2026

Optimizing PSMA-617-based inhibitors through charged linker modifications: Insights into structure-activity relationshipsNicolas M Geis, Yvonne Braunwarth, Philipp T Meyer, et al.

Theranostics|September 6, 2024

Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptideMohamed El Fakiri, Anusha R Regupathy, Lisa Uhlmann, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 29, 2024

Development and Preclinical Evaluation of [<sup>211</sup>At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate CancerMohamed El Fakiri, Nawal Ayada, Marius Müller, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Cancers|August 27, 2021

PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future PerspectivesMohamed El Fakiri, Nicolas M Geis, Nawal Ayada, et al.

Theranostics|January 9, 2026

Optimizing PSMA-617-based inhibitors through charged linker modifications: Insights into structure-activity relationshipsNicolas M Geis, Yvonne Braunwarth, Philipp T Meyer, et al.

Theranostics|September 6, 2024

Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptideMohamed El Fakiri, Anusha R Regupathy, Lisa Uhlmann, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 29, 2024

Development and Preclinical Evaluation of [<sup>211</sup>At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate CancerMohamed El Fakiri, Nawal Ayada, Marius Müller, et al.

Pageof 1